CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-02 | Campoy Carlos Chief Financial Officer | Grant or award | +22,500 | 28,921 | ||
| 2022-02-02 | Campoy Carlos Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2022-02-02 | McCarthy Sean A. President and CEO | Grant or award | +75,000 | 174,922 | ||
| 2022-02-02 | McCarthy Sean A. President and CEO | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 | ||
| 2021-10-24 | McCarthy Sean A. President and CEO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-10-24 | McCarthy Sean A. President and CEO | Grant or award · Performance Stock Units (PSUs) | +80,000 | 80,000 | ||
| 2021-10-24 | ROWLAND LLOYD A General Counsel | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-10-24 | ROWLAND LLOYD A General Counsel | Grant or award · Performance Stock Units (PSUs) | +30,000 | 30,000 | ||
| 2021-10-24 | Peterson Amy C. EVP, Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-10-24 | Peterson Amy C. EVP, Chief Development Officer | Grant or award · Performance Stock Units (PSUs) | +40,000 | 40,000 | ||
| 2021-10-24 | Campoy Carlos Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-10-24 | Campoy Carlos Chief Financial Officer | Grant or award · Performance Stock Units (PSUs) | +30,000 | 30,000 | ||
| 2021-10-24 | HANNAH ALISON L. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-10-24 | HANNAH ALISON L. Chief Medical Officer | Grant or award · Performance Stock Units (PSUs) | +30,000 | 30,000 | ||
| 2021-09-29 | Ashworth Alan Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-08-11 | McCarthy Sean A. President and CEO | Option exercise | +92,113 | $1.13 | $104K | 99,922 |
| 2021-08-11 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −92,113 | 0 | ||
| 2021-06-16 | McCarthy Sean A. President and CEO | Sale | −100,000 | $7.04 | $704K | 93,118 |
| 2021-06-16 | Mohindru Mani Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-16 | Young Matthew P. Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 12 of 33 · 649 trades